Mark W. Kroll - May 26, 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
Director
Signature
/s/ Thomas V. Powers, attorney-in-fact for Dr. Kroll
Stock symbol
HAE
Transactions as of
May 26, 2021
Transactions value $
-$283,339
Form type
4
Date filed
5/28/2021, 04:09 PM
Previous filing
May 14, 2021
Next filing
Jun 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $368K +10.4K +52.03% $35.50 30.3K May 26, 2021 Direct F1, F2
transaction HAE Common Stock Sale -$651K -11.8K -39.05% $55.10 18.4K May 26, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -10.4K -100% $0.00* 0 May 26, 2021 Common Stock 10.4K $35.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person exercised options that were granted in 2014 and scheduled to expire on July 23, 2021, as reflected in this Form 4.
F2 This number includes unvested restricted stock units previously reported.
F3 Option vests 100% on the first anniversary of the date of grant.